DNA Copy Number Losses in Human Neoplasms
Open accessThe DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 2×
“3) is a primary-response gene for p53, involved in a p53regulated pathway for induction of apoptosis.177 BAX forms heterodimers with BCL2 and reduces the deathrepressing activity of BCL2.”
BackgroundThe p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“Band 9p21 contains a tumor suppressor gene, CDKN2A (cyclin-dependent kinase inhibitor 2A), which encodes a cell-cycle inhibitor, p16.(59,60) Deletions at the locus often encompass and inactivate a gene nearby, CDKN2B (p15), which has similar functions as CDKN2A.”
BackgroundIdentification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948 · cited 2×
“3 is one of the best studied tumor suppressor genes.122–124 Hereditary retinoblastoma is caused by a germline mutation of RB1.”
ResultA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337 · cited 1×
“DPC4, a member of the MAD gene family, is involved in signal transduction of serine threonine kinase receptors.(158) Its inactivation occurs in almost half of pancreatic carcinomas(158) but is uncommon in other tumor types.”
BackgroundLocalization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K., Seal, S., Tran, T., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,924
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,739
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,136
Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor
Keino-Masu, K., Masu, M., Hinck, L., Leonardo, E. D., Chan, S. S.-Y., Culotti, J. G., & Tessier-Lavigne, M. (1996) · Cell · doi:10.1016/s0092-8674(00)81336-7 · Cited by 1,013
Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81034-x · Cited by 990
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
Martin, G. A., Viskoohil, D., Bollag, G., McCabe, P. C., Crosier, W. J., Haubruck, H., Conroy, L., Clark, R., O'Connell, P., Cawthon, R. M., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90150-d · Cited by 982
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marin, M. C., & Jr, W. G. K. (1997) · Nature · doi:10.1038/38298 · Cited by 948
Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., & Ohki, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10431 · Cited by 872 · cited 1×
“AML1 encodes a DNAbinding subunit of the AML1/CBFB transcription factor complex.(113) This translocation is the most common molecular genetic aberration of childhood ALL, occurring in approximately 25% of the patients, and it is associated with a favorable outcome.”
BackgroundEppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I. L., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80128-2 · Cited by 845
Structural Evidence for the Authenticity of the Human Retinoblastoma Gene
Fung, Y.-K. T., Murphree, A. L., T'Ang, A., Qian, J., Hinrichs, S. H., & Benedict, W. F. (1987) · Science · doi:10.1126/science.2885916 · Cited by 780
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Role of the p16 tumor suppressor gene in cancer.
Liggett, W. H., & Sidransky, D. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1197 · Cited by 746
Kallioniemi, A., Kallioniemi, O. P., Piper, J., Tanner, M., Stokke, T., Chen, L., Smith, H. S., Pinkel, D., Gray, J. W., & Waldman, F. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2156 · Cited by 739
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
Golub, T. R., Barker, G. F., Bohlander, S. K., Hiebert, S. W., Ward, D. C., Bray-Ward, P., Morgan, E., Raimondi, S. C., Rowley, J. D., & Gilliland, D. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4917 · Cited by 704
Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R. E., & Ellenson, L. H. (1997) · PubMed · Cited by 701
DPC4 gene in various tumor types.
Schutte, M. E. M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., et al. (1996) · PubMed · Cited by 672
Le Beau, M. M., Albain, K. S., Larson, R. A., Vardiman, J. W., Davis, E. M., Blough, R. R., Golomb, H. M., & Rowley, J. D. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.3.325 · Cited by 671
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16INK4Mutations
Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 622
Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81132-0 · Cited by 609
Wild-type p53 activates transcription in vitro
Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., & Prives, C. (1992) · Nature · doi:10.1038/358083a0 · Cited by 579 · cited 1×
“It codes for a protein, p53, that acts as a transcription factor and prevents damaged DNA from replicating.(151,152) Losses or other inactivating mutations in TP53 are possibly the most common genetic DNA Copy Number Losses in Human Neoplasms 687 AJP September 1999, Vol.”
BackgroundEvidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
Ruttledge, M. H., Sarrazin, J., Rangaratnam, S., Phelan, C. M., Twist, E. C., Merel, P., Delattre, O., Thomas, G. D., Nordenskjöld, M., Collins, V. P., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-180 · Cited by 573
Knuutila, S., Björkqvist, A.-M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O. M., Szymańska, J., Larramendy, M. L., Tapper, J., Pere, H., et al. (1998) · PubMed · Cited by 567
Self-citationShurtleff, S. A., Buijs, A., Behm, F. G., Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G., Pui, C., Grosveld, G. C., & Downing, J. R. (1995) · PubMed · Cited by 547
The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion
Romana, S., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R., & Bernard, O. (1995) · Blood · doi:10.1182/blood.v85.12.3662.bloodjournal85123662 · Cited by 530
Hemminki, A., Tomlinson, I., Markie, D., Järvinen, H., Sistonen, P., Björkqvist, A.-M., Knuutila, S., Salovaara, R., Bodmer, W., Shibata, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-87 · Cited by 491
Self-citationLocalization of gene for human p53 tumour antigen to band 17p13
Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986) · Nature · doi:10.1038/320084a0 · Cited by 485
BRCA1 is a component of the RNA polymerase II holoenzyme
Scully, R., Anderson, S. F., Chao, D. M., Wei, W., Ye, L., Young, R. A., Livingston, D. M., & Parvin, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5605 · Cited by 454
The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis
Mehlen, P., Rabizadeh, S., Snipas, S. J., Assa-Munt, N., Salvesen, G. S., & Bredesen, D. E. (1998) · Nature · doi:10.1038/27441 · Cited by 437
APC gene: database of germline and somatic mutations in human tumors and cell lines
Beroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.121 · Cited by 420
Deletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
Tanaka, K., Miura, N., Satokata, I., Miyamoto, I., Yoshida, M. C., Satoh, Y., Kondo, S., Yasui, A., Okayama, H., & Okada, Y. (1990) · Nature · doi:10.1038/348073a0 · Cited by 388
Alterations of the PPP2R1B Gene in Human Lung and Colon Cancer
Wang, S. S., Esplin, E. D., Li, J. L., Huang, L., Gazdar, A., Minna, J., & Evans, G. A. (1998) · Science · doi:10.1126/science.282.5387.284 · Cited by 363
Tirkkonen, M., Johannsson, O. T., Agnarsson, B. A., Olsson, H. L., Ingvarsson, S., Karhu, R., Tanner, M., Isola, J. J., Barkardottir, R. B., Borg, Å., et al. (1997) · PubMed · Cited by 354
Yuan, B., Miller, M. J., Keck, C. L., Zimonjic, D. B., Thorgeirsson, S. S., & Popescu, N. C. (1998) · PubMed · Cited by 334
McLean, T., Ringold, S., Neuberg, D., Stegmaier, K., Tantravahi, R., Ritz, J., Koeffler, H., Takeuchi, S., Janssen, J., Seriu, T., et al. (1996) · Blood · doi:10.1182/blood.v88.11.4252.4252 · Cited by 323
Borkhardt, A., Cazzaniga, G., Viehmann, S., Valsecchi, M. G., Ludwig, W. D., Burci, L., Mangioni, S., Schrappe, M., Riehm, H., Lampert, F., et al. (1997) · Blood · doi:10.1182/blood.v90.2.571 · Cited by 319
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
Cheng, J. Q., Jhanwar, S., Klein, W. M., Bell, D. W., Lee, W.-C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A., & Testa, J. R. (1994) · PubMed · Cited by 319
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation
Garkavtsev, I., Kazarov, A., Gudkov, A., & Riabowol, K. (1996) · Nature Genetics · doi:10.1038/ng1296-415 · Cited by 300
The CDKN2A (p16) Gene and Human Cancer
Foulkes, W. D., Flanders, T. Y., Pollock, P. M., & Hayward, N. K. (1997) · Molecular Medicine · doi:10.1007/bf03401664 · Cited by 292
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei, E., Kang, L., Bogomolniy, F., Federici, M. G., Borgen, P. I., & Boyd, J. (1997) · PubMed · Cited by 290
Hebert, J., Cayuela, J., Berkeley, J., & Sigaux, F. (1994) · Blood · doi:10.1182/blood.v84.12.4038.bloodjournal84124038 · Cited by 281
Richter, J., Jiang, F., Görög, J. P., Sartorius, G. A., Egenter, C., Gasser, T. C., Moch, H., Mihatsch, M. J., & Sauter, G. (1997) · PubMed · Cited by 251
Raynaud, S., Cave, H., Baens, M., Bastard, C., Cacheux, V, Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P., et al. (1996) · Blood · doi:10.1182/blood.v87.7.2891.bloodjournal8772891 · Cited by 242
ZIP Kinase, a Novel Serine/Threonine Kinase Which Mediates Apoptosis
Kawai, T., Matsumoto, M., Takeda, K., Sanjo, H., & Akira, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1642 · Cited by 236
Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray, I. C., Phillips, S. M. A., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., & Spurr, N. K. (1995) · PubMed · Cited by 232
Liu, Y., Corcoran, M., Rasool, O., Ivanova, G., Ibbotson, R., Grandér, D., Iyengar, A., Baranova, A., Kashuba, V., Merup, M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201643 · Cited by 215
Allelotype analysis of cervical carcinoma.
Mitra, A., Murty, V. V. V. S., Li, R. G., Pratap, M., Luthra, U. K., & CHAGANTI, R. S. K. (1994) · PubMed · Cited by 205
Rubnitz, J. E., Downing, J. R., Pui, C. H., Shurtleff, S. A., Raimondi, S. C., Evans, W. E., Head, D. R., Crist, W. M., Rivera, G. K., Hancock, M. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1150 · Cited by 197
Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia
Okuda, T., Shurtleff, S., Valentine, M., Raimondi, S., Head, D., Behm, F., Curcio- Brint, A., Liu, Q., Pui, C., & Sherr, C. (1995) · Blood · doi:10.1182/blood.v85.9.2321.bloodjournal8592321 · Cited by 192
Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins
Park, C. H., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5017 · Cited by 189
6q deletions define distinct clinico-pathologic subsets of non- Hodgkin's lymphoma
Offit, K., Parsa, N., Gaïdano, G., Filippa, D., Louie, D. C., Pan, D., Jhanwar, S. C., Dalla‐Favera, R., & CHAGANTI, R. S. K. (1993) · Blood · doi:10.1182/blood.v82.7.2157.2157 · Cited by 187
The H-cadherin ( CDH13 ) gene is inactivated in human lung cancer
Sato, M., Mori, Y., Sakurada, A., Fujimura, S., & Horii, A. (1998) · Human Genetics · doi:10.1007/s004390050790 · Cited by 167
Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M. J., Singh, A. D., Shields, J. A., Shields, C. L., & Croce, C. M. (1994) · PubMed · Cited by 165
Johansson, B., Mertens, F., & Mitelman, F. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870080402 · Cited by 163
Varrault, A., Ciani, E., Apiou, F., Bilanges, B., Hoffmann, A., Pantaloni, C., Bockaert, J., Spengler, D., & Journot, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8835 · Cited by 162
Kim, S. K., Fan, Y.-H., Papadimitrakopoulou, V. A., Clayman, G. L., Hittelman, W. N., Hong, W. K., Lotan, R., & Mao, L. (1996) · PubMed · Cited by 159
Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Le Dai, J., Kern, S. E., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2412 · Cited by 158
Takeuchi, S., Bartram, C., Seriu, T., Cw, M., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W., Zimmermann, M., & Schwaller, J. (1995) · Blood · doi:10.1182/blood.v86.2.755.bloodjournal862755 · Cited by 156
Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A. A., Brewer, C. G., Liao, S., Busby-Earle, R., Williams, A. W., Steel, C. M., & Bird, C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.6953 · Cited by 150
Weinberg, R. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90177-s · Cited by 147
Filippova, G. N., Lindblom, A., Meincke, L., Klenova, E. M., Neiman, P. E., Collins, S. J., Doggett, N. A., & Lobanenkov, V. V. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199805)22:1<26::aid-gcc4>3.0.co;2-9 · Cited by 147
Software and database for the analysis of mutations in the VHL gene
Béroud, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.256 · Cited by 143
p16 gene homozygous deletions in acute lymphoblastic leukemia
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Laï, J., Bauters, F., Wattel, E., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.3.657.bloodjournal853657 · Cited by 139
Gao, X., Honn, K. V., Grignon, D. J., Sakr, W., & Chen, Y. Q. (1993) · PubMed · Cited by 139
Characterization of molecular defects in xeroderma pigmentosum group C
Li, L., Bales, E. S., Peterson, C. A., & Legerski, R. J. (1993) · Nature Genetics · doi:10.1038/ng1293-413 · Cited by 136
Stilgenbauer, S., Liebisch, P., James, M. R., Schröder, M., Schlegelberger, B., Fischer, K., Bentz, M., Lichter, P., & Döhner, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11837 · Cited by 136
Hong, L., Fairman, J., Claxton, D. F., Nowell̀, P. C., Green, E. D., & Nagarajan, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3781 · Cited by 134
Identification of a Third EXT-like Gene (EXTL3) Belonging to the EXT Gene Family
Hul, W. V., Wuyts, W. A., Hendrickx, J., Speleman, F., Wauters, J., Boulle, K. D., Roy, N. V., Bossuyt, P., & Willems, P. J. (1998) · Genomics · doi:10.1006/geno.1997.5101 · Cited by 130
APC gene: database of germline and somatic mutations in human tumors and cell lines
Laurent-Puig, P. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.269 · Cited by 130
Höhne, M. W., Halatsch, M., Kahl, G. F., & Weinel, R. J. (1992) · PubMed · Cited by 128
Habuchi, T., Luscombe, M., Elder, P. A., & Knowles, M. A. (1998) · Genomics · doi:10.1006/geno.1997.5165 · Cited by 126
Mælandsmo, G. M., Berner, J. M., Flørenes, V. A., Forus, A., Hovig, E. J., Fodstad, Ø., & Myklebost, O. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.344 · Cited by 120
Seitz, S., Rohde, K., Bender, E., Nothnagel, A., Kölble, K., Schlag, P. M., & Scherneck, S. (1997) · Oncogene · doi:10.1038/sj.onc.1200881 · Cited by 118
Zenklusen, J. C., Thompson, J. C., Klein-Szanto, A. J., et al. (1995) · PubMed · Cited by 114
El-Rifai, W. M., Larramendy, M. L., Björkqvist, A., Hemmer, S., & Knuutila, S. (1997) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 110
Self-citationFizzotti, M., Cimino, G. G., Pisegna, S., Alimena, G., Quartarone, C., Mandelli, F., Pelicci, P. G., & Coco, F. L. (1995) · Blood · doi:10.1182/blood.v85.10.2685.bloodjournal85102685 · Cited by 110
Wick, W., Petersen, I., Schmutzler, R., Wolfarth, B., Lenartz, D., Bierhoff, E., Hümmerich, J., Dj, M., Ap, S., Schramm, J., et al. (1996) · PubMed · Cited by 108
Novel suppressor loci on chromosome 14q in primary bladder cancer.
Chang, W. Y., Cairns, P., Schoenberg, M., Polascik, T. J., & Sidransky, D. (1995) · PubMed · Cited by 105
ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia
Cavé, H., Cacheux, V., Raynaud, S., Brunie, G., Bakkus, M. H. C., Cochaux, P., Preudhomme, C., Laï, J., VILMER, E., & Grandchamp, B. (1997) · Leukemia · doi:10.1038/sj.leu.2400798 · Cited by 104
Fujiwara, Y., Ohata, H., Kuroki, T., Koyama, K., Tsuchiya, E., Monden, M., & Nakamura, Y. (1995) · PubMed · Cited by 98
Allelotype of endometrial carcinoma.
Fujino, T., Risinger, J. I., Collins, N. K., Liu, F.-S., Nishii, H., Takahashi, H., Westphal, E., Barrett, J. C., Sasaki, H., & Kohler, M. F. (1994) · PubMed · Cited by 94
Differential expression of Rb2/p130 and p107 in normal human tissues and in primary lung cancer.
Baldi, A., Esposito, V., Luca, A. D., Fu, Y., Meoli, I., Giordano, G., Caputi, M., Baldi, F., & Giordano, A. (1997) · PubMed · Cited by 94
Allelic loss in ovarian cancer
Yang‐Feng, T. L., Han, H. R., Chen, K., Li, S., Claus, E. B., Carcangiu, M. L., Chambers, S. K., Chambers, J. T., & Schwartz, P. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540405 · Cited by 94
Schultz, D., Vanderveer, L., Buetow, K. H., Boente, M. P., Ozols, R. F., Hamilton, T. C., & Godwin, A. K. (1995) · PubMed · Cited by 92
Maestro, R., Piccinin, S., Doglioni, C., Gasparotto, D., Vukosavljevic, T., Sulfaro, S., Barzan, L., & Boiocchi, M. (1996) · PubMed · Cited by 83
Susini, T., Baldi, F., Howard, C. M., Baldi, A., Taddei, G. L., Massi, D., Rapi, S., Savino, L., Massi, G., & Giordano, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1085 · Cited by 83
Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
Davis, M., Hitchcock, A., Foulkes, W. D., & Campbell, I. (1996) · PubMed · Cited by 81
Lowsky, R., DeCoteau, J. F., Reitmair, A. H., Ichinohasama, R., Dong, W.-F., Xu, Y., Mak, T. W., Kadin, M. E., & Minden, M. D. (1997) · Blood · doi:10.1182/blood.v89.7.2276 · Cited by 78
Rotman, G., & Shiloh, Y. (1997) · PubMed · Cited by 78
Habuchi, T., Yoshida, O., & Knowles, M. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.913 · Cited by 77
Johnson, R. T., & Squires, S. (1992) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(92)90072-b · Cited by 76
Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas
Shridhar, V., Sun, Q. C., Miller, O. J., Kalemkerian, G. P., Petros, J. A., & Smith, D. I. (1997) · Oncogene · doi:10.1038/sj.onc.1201448 · Cited by 76
Hammoud, Z. T., Kaleem, Z., Cooper, J. D., Sundaresan, R. S., Patterson, G. A., & Goodfellow, P. J. (1996) · PubMed · Cited by 75
Liang, D.-C., Chou, T.-B., Chen, J.-S., Shurtleff, S. A., Rubnitz, J. E., Downing, J. R., Pui, C., & Shih, L. (1996) · PubMed · Cited by 74
Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer
Yang‐Feng, T. L., Li, S., Han, H. J., & Schwartz, P. E. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520414 · Cited by 73
Sheng, Z., Marchetti, A., Buttitta, F., Champeme, M.-H., Campani, D., Bistocchi, M., Lidereau, R., & Callahan, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.27 · Cited by 71
Heyman, M. M., Rasool, O., Brandter, L., Liu, Y., Grandér, D., Söderhäll, S., Gustavsson, G., & Einhorn, S. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1512 · Cited by 71
The von Hippel-Lindau tumor suppressor gene
Decker, H. J., Weidt, E. J., & Brieger, J. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00296-8 · Cited by 69
Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas
Herbers, J., Schullerus, D., Müller, H., Kenck, C., Chudek, J. T., Weimer, J. P., Bugert, P., & Kovács, G. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199705)19:1<29::aid-gcc5>3.0.co;2-2 · Cited by 69
Wright, K., Wilson, P. J., Kerr, J., Do, K., Hurst, T., Khoo, S., Ward, B. G., & Chenevix‐Trench, G. (1998) · Oncogene · doi:10.1038/sj.onc.1202028 · Cited by 68
Inactivation of Smad4 in gastric carcinomas.
Powell, S. M., Harper, J. C., Hamilton, S. R., Robinson, C., & Cummings, O. W. (1997) · PubMed · Cited by 67
Physical mapping of the minimal region of loss in 5q- chromosome.
Fairman, J., Chumakov, I. M., Chinault, A. C., Nowell̀, P. C., & Nagarajan, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7406 · Cited by 66
Chromosome 10 alterations in prostate adenocarcinoma (review).
Ittmann, M. (1998) · Oncology Reports · doi:10.3892/or.5.6.1329 · Cited by 62
A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.
Herbst, R. A., Larson, A. A., Weiss, J., Cavenee, W. K., Hampton, G. M., & Arden, K. C. (1995) · PubMed · Cited by 61
Localization of the gene for the nevoid basal cell carcinoma syndrome.
Goldstein, A. M., Stewart, C., Bale, A. E., Bale, S. J., & Dean, M. C. (1994) · PubMed · Cited by 56
van Bakel, I., Sepp, T., Ward, S., Yates, J. R., & Green, A. J. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.9.1409 · Cited by 56
Bench, A. J., Aldred, M. A., Humphray, S., Champion, K. M., Gilbert, J. G. R., Asimakopoulos, F. A., Deloukas, P., Gwilliam, R., Bentley, D. R., & Green, A. R. (1998) · Genomics · doi:10.1006/geno.1998.5231 · Cited by 52
Genetics and cytogenetics of retinoblastoma
Cowell, J. K., & Hogg, A. (1992) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(92)90314-x · Cited by 49
Takeuchi, S., Seriu, T., Bartram, C., Golub, T. R., Reiter, A., Miyoshi, I., Gilliland, D. G., & Koeffler, H. (1997) · Leukemia · doi:10.1038/sj.leu.2400743 · Cited by 48
Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas
Choi, C., Cho, S., Horikawa, I., Berchuck, A., Wang, N., Cedrone, E., Juhng, S., Lee, J. B., Kerr, J., Chenevix‐Trench, G., et al. (1997) · Genes Chromosomes and Cancer · Cited by 47
Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
Bell, D. W., Jhanwar, S., & Testa, J. R. (1997) · PubMed · Cited by 46
The Nevoid Basal Cell Carcinoma Syndrome: Genetics and Mechanism of Carcinogenesis
Bale, A. E. (1997) · Cancer Investigation · doi:10.3109/07357909709115772 · Cited by 45
Edelson, M. I., Scherer, S. W., Tsui, L. ‐., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201271 · Cited by 44
Liu, J., Nau, M. M., Zucman‐Rossi, J., Powell, J. I., Allegra, C. J., & Wright, J. J. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199703)18:3<175::aid-gcc4>3.3.co;2-r · Cited by 43
Suzuki, K., Ogura, T., Yokose, T., Nagai, K., Mukai, K., Kodama, T., Nishiwaki, Y., & Esumi, H. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<384::aid-ijc13>3.0.co;2-5 · Cited by 42
Fine mapping of a region of common deletion on chromosome arm 10p in human glioma
Voesten, A. M. J., Bijleveld, E. H., Westerveld, A., & Hulsebos, T. J. M. (1997) · Genes Chromosomes and Cancer · Cited by 38
Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation
Heinen, C. D., Noffsinger, A. E., Belli, J., Straughen, J. E., Fischer, J. E., Groden, J. L., & Fenoglio‐Preiser, C. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<156::aid-gcc4>3.0.co;2-x · Cited by 36
Loss of heterozygosity on the X chromosome in human breast cancer
Loupart, M., Adams, S., Armour, J. A. L., Walker, R. A., Brammar, W. J., & Varley, J. M. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130402 · Cited by 25
Flejter, W. L., McDaniel, L. D., Askari, M. D. F., Friedberg, E. C., & Schultz, R. A. (1992) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870050409 · Cited by 19
Cited by
Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
“FBW7 is located within 4q32, a chromosomal region that is commonly deleted in cancer”
BackgroundPhosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase
Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065203 · Cited by 762
The Ubiquitin-Proteasome Pathway and Its Role in Cancer
Mani, A., & Gelmann, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.081 · Cited by 549
Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468
miR‐15a and miR‐16‐1 down‐regulation in pituitary adenomas
Bottoni, A., Piccin, D., Tagliati, F., Luchin, A., Zatelli, M. C., & Degli Uberti, E. C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20282 · Cited by 360
Metadata
- Authors
- Knuutila, S., Aalto, Y., Autio, K., Björkqvist, A.-M., El-Rifai, W., Hemmer, S., Huhta, T., Kettunen, E., Kiuru-Kuhlefelt, S., Larramendy, M. L., Lushnikova, T., Monni, O., Pere, H., Tapper, J., Tarkkanen, M., Varis, A., Wasenius, V.-M., Wolf, M., & Zhu, Y.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 155
- Issue
- 3
- Pages
- 683-694
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2074809432
- Cited by
- 397
- References
- 140
- FWCI
- 23.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.